FKBP5 and attention deficit-hyperactivity disorder: In addition, FKBP5 was associated with MDD [111], bipolar disorder [112], schizophrenia [113], posttraumatic stress disorder [114, 115], attention deficit hyperactivity disorder (ADHD) [116], chronic pain [117, 118] and metabolic dysfunction, insulin resistance and obesity [119, 120].